Evaluation of recombinant transferrin-binding protein B variants from Neisseria meningitidis for their ability to induce cross-reactive and bactericidal antibodies against a genetically diverse collection of serogroup B strains

Infection and Immunity

Volumn 65, Issue 1, 1997, Pages 55-63

  Rokbi, Bachra ^a   Mignon, Michèle ^a   Maitre Wilmotte, Ghislaine ^a   Lissolo, Ling ^a   Danve, Bernard ^a   Caugant, Dominique A ^b   Quentin Millet, Marie José ^a  

^a Pasteur Merieux Serums et Vaccins   (France)

^b NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; CROSS REACTING ANTIBODY; RECOMBINANT PROTEIN; TRANSFERRIN;

ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; CROSS REACTION; GENETIC VARIABILITY; NEISSERIA MENINGITIDIS; NONHUMAN; PRIORITY JOURNAL; RABBIT; SERUM BACTERICIDAL ACTIVITY;

EID: 0031032906     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.65.1.55-63.1997     Document Type: Article

References (55)

1. Ala'Aldeen, D. A. 1996. Transferrin receptors of Neisseria meningitidis: promising candidates for a broadly cross-reactive vaccine. J. Med. Microbiol. 44:237-243.
2. Ala'Aldeen, D. A. A., and S. P. Borriello. 1996. The meningococcal transferrin-binding proteins 1 and 2 are both surface exposed and generate bactericidal antibodies capable of killing homologous and heterologous strains. Vaccine 14:49-53.
3. Ala'Aldeen, D. A., N. B. Powell, R. A. Wall, and S. P. Borriello. 1993. Localization of the meningococcal receptors for human transferrin. Infect. Immun. 61:751-759.
4. Ala'Aldeen, D. A. A., P. Stevenson, E. Griffiths, A. R. Gorringe, L. I. Irons, A. Robinson, S. Hyde, and S. P. Borriello. 1994. Immune responses in humans and animals to meningococcal transferrin-binding proteins: implications for vaccine design. Infect. Immun. 62:2984-2990.
5. Anderson, J. E., P. F. Sparling, and C. N. Cornelissen. 1994. Gonococcal transferrin-binding protein 2 facilitates but is not essential for transferrin utilization. J. Bacteriol. 176:3162-3170.
6. Banerjee-Bathnagar, N., and C. E. Frasch. 1990. Expression of Neisseria meningitidis iron-regulated outer membrane proteins, including a 70-kilodalton transferrin receptor, and their potential use as vaccines. Infect. Immun. 58:2875-2881.
7. Bjune, G., E. A. Høiby, J. K. Grønnesby, O. Arnesen, J. H. Fredriksen, A. Halstensen, E. Holten, A. K. Lindbak, H. Nøkleby, E. Rosenqvist. 1991. Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway. Lancet 338:1093-1096.
8. Caugant, D. A., K. Bøvre, P. Gaustad, K. Bryn, E. Holten, E. A. Høiby, and L. O. Frøholm. 1986. Multilocus genotypes determined by enzyme electrophoresis of Neisseria meningitidis isolated from patients with systemic disease and from healthy carriers. J. Gen. Microbiol. 132:641-652.
9. Caugant, D. A., L. O. Frøholm, K. Bøvre, E. Holten, C. E. Frasch, L. F. Mocca, W. D. Zollinger, and R. K. Selander. 1986. Intercontinental spread of a genetically distinctive complex of clones of Neisseria meningitidis causing epidemic disease. Proc. Natl. Acad. Sci. USA 83:4927-4931.
10. Caugant, D. A., P. Bol, E. A. Høiby, H. C. Zanen, and L. O. Frøholm. 1990. Clones of serogroup B Neisseria meningitidis causing systemic disease in the Netherlands, 1958 through 1986. J. Infect. Dis. 162:867-874.
11. Cornelissen, C. N., G. D. Biswas, J. Tsai, D. K. Paruchuri, S. A. Thompson, and F. Sparling. 1992. Gonococcal transferrin-binding protein 1 is required for transferrin utilization and is homologous to TonB dependent outer membrane receptors. J. Bacteriol. 174:5788-5797.
12. Cornelissen, C. N., and P. F. Sparling. 1996. Binding and surface exposure characteristics of the gonococcal transferrin receptor are dependent on both transferrin-binding proteins. J. Bacteriol. 178:1437-1444.
13. Danve, B., L. Lissolo, M. Mignon, P. Dumas, S. Colombani, A. B. Schryvers, and M. J. Quentin-Millet. 1993. Transferrin-binding proteins isolated from Neisseria meningitidis elicit protective and bactericidal antibodies in laboratory animals. Vaccine 11:1214-1220.
14. De Moraes, J. C., B. A. Perkins, M. C. Camargo, N. T. Hidalgo, H. A. Barbosa, C. T. Sacchi, I. M. Landgraf, V. L. Gattas, and G. H. de Vasconcelos. 1992. Protective efficacy of a serogroup B meningococcal vaccine in Sao Paulo, Brazil. Lancet 340:1074-1078.
15. Dyer, D. W., E. P. West, W. McKenna, S. A. Thompson, and P. F. Sparling. 1988. A pleiotropic iron-uptake mutant of Neisseria meningitidis lacks a 70-kilodalton iron-regulated protein. Infect. Immun. 56:977-983.
16. Ferreiros, C. M., M. T. Criado, M. Pintor, and L. Ferron. 1991. Analysis of the molecular mass heterogeneity of the transferrin receptor in Neisseria meningitidis and commensal Neisseria. FEMS Microbiol. Lett. 83:247-254.
17. Ferron, L., C. M. Ferreiros, M. T. Criado, and M. Pintor. 1992. Immunogenicity and antigenic heterogeneity of a human transferrin-binding protein in Neisseria meningitidis. Infect. Immun. 60:2887-2892.
18. Gerlach, G. F., C. Anderson, A. A. Potter, S. Klasninsky, and P. J. Willson, 1992. Cloning and expression of a transferrin binding protein from Actinobacillus pleuropneumoniae. Infect. Immun. 60:892-898.
19. Gorringe, A. R., R. Borrow, A. J. Fox, and A. Robinson. 1995. Human antibody response to meningococcal transferrin binding proteins: evidence for vaccine potential. Vaccine 13:1207-1212.
20. Griffiths, E., P. Stevenson, and A. Ray. 1990. Antigenic and molecular heterogeneity of the transferrin binding protein of Neisseria meningitidis. FEMS Microbiol. Lett. 69:31-36.
21. Harlow, Z., and D. Lane. 1988. Antibodies: a laboratory manual, p. 312. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
22. Kasper, D. L., J. L. Winkelhake, B. L. Brandt, and M. S. Arteinstein. 1973. Antigen specificity of bactericidal antibodies in antisera to Neisseria meningitidis. J. Infect. Dis. 127:378-387.
23. Kunkel, T. A. 1985. Rapid and efficient site-specific mutagenesis without phenotypic selection. Proc. Natl. Acad. Sci. USA 82:488-492.
24. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
25. Legrain, M., V. Mazarin, S. W. Irwin, B. Bouchon, M. J. Quentin-Millet, E. Jacobs, and A. B. Schryvers. 1993. Cloning and characterization of Neisseria meningitidis genes encoding the transferrin-binding proteins Tbp1 and Tbp2. Gene 130:73-80.
26. Legrain, M., D. Speck, and E. Jacobs. 1995. Production of lipidated meningococcal transferrin binding protein 2 in Escherichia coli. Protein Expression Purif. 6:570-578.
27. Lewis, L. A., and D. W. Dyer. 1995. Identification of an iron-regulated outer membrane protein of Neisseria meningitidis involved in the utilization of hemoglobin complexed to haptoglobin. J. Bacteriol. 177:1299-1306.
28. Lissolo, L., G. Maitre-Wilmotte, P. Dumas, M. Mignon, B. Danve, and M. J. Quentin-Millet. 1995. Evaluation of transferrin-binding protein 2 within the transferrin-binding protein complex as a potential antigen for future meningococcal vaccines. Infect. Immun. 63:884-890.
29. Loosmore, S. M., V. P. Yang, D. C. Coleman, J. M. Shortreed, D. M. England, R. E. Harkness, P. S. C. Chong, and M. H. Klein. 1996. Cloning and expression of the Haemophilus influenzae transferrin receptor genes. Mol. Microbiol. 19:575-586.
30. Mandrell, R. E., and W. D. Zollinger. 1989. Human immune response to meningococcal outer membrane protein epitopes after natural infection or vaccination. Infect. Immun. 57:1590-1594.
31. Mazarin, V., B. Rokbi, and M. J. Quentin-Millet. 1995. Genetic diversity of the transferrin-binding protein Thp2 of Neisseria meningitidis. Gene 158:145-146.
32. Mietzner, T. A., G. H. Luginbhul, E. Sandstrom, and S. A. Morse. 1984. Identification of an iron-regulated 37,000-dalton protein in cell envelope of Neisseria gonorrhoeae. Infect. Immun. 45:410-416.
33. Milagres, L. G., A. P. S. Lemos, C. E. A. Meles, E. L. Silva, L. H. M. L. Ferreira, J. A. M. Souza, and G. M. Carlone. 1995. Antibody response after immunization of Brazilian children with serogroup C meningococcal polysaccharide noncovalently complexed with outer membrane proteins. Braz. J. Med. Biol. Res. 28:981-989.
34. Milagres, L. G., S. R. Ramos, C. T. Sacchi, C. E. A. Melles, V. S. D. Vieira, H. Sato, G. S. Brito, J. C. Moraes, and C. E. Frasch. 1994. Immune response of brazilian children to a Neisseria meningitidis serogroup B outer membrane protein vaccine: comparison with efficacy. Infect. Immun. 62:4419-4424.
35. Pitcher, D. G., N. A. Saunders, and R. J. Owen. 1989. Rapid extraction of bacterial genomic DNA with guanidium thiocyanate. Lett. Appl. Microbiol. 8:151-156.
36. Poolman, J. T. 1995. Development of a meningococcal vaccine. Infect. Agent Dis. 4:13-28.
37. Poolman, J. T. 1991. Molecular immunological analysis of meningococcal class 1 outer membrane protein and lipopolysaccharide. Trans. R. Soc. Trop. Med. Hyg. 1:23-27.
38. Poolman, J. T., and H. Abdillahi. 1988. Outer membrane protein serosubtyping of Neisseria meningitidis. Eur. J. Clin. Microbiol. Infect. Dis. 7:291-292.
39. Rokbi, B., G. Maitre-Wilmotte, V. Mazarin, L. Fourrichon, L. Lissolo, and M. J. Quentin-Millet. 1995. Variable sequences in a mosaic-like domain of meningococcal tbp2 encode immunoreactive epitopes. FEMS Microbiol. Lett. 132:277-283.
40. Rokbi, B., V. Mazarin, G. Maitre-Wilmotte, and M. J. Quentin-Millet. 1993. Identification of two major families of transferrin receptors among Neisseria meningitidis strains based on antigenic and genomic features. FEMS Microbiol. Lett. 110:51-57.
41. Rosenqvist, E., E. A. Hoiby, G. Bjune, K. Bryn, D. A. Caugant, O. Closs, J. K. Fredricksen, J. K. Gronnesby, H. Nokleby, E. Wedege, and L. O. Froholm. 1992. Meningococcal group B outer membrane vesicle vaccine trial among teen-agers in Norway. Adv. Mod. Biotechnol. La Habana 1:5-12.
42. Rossi-Campos, A., C. Anderson, G. F. Gerlach, A. A. Potter, and P. J. Wilson. 1992. Immunisation of pigs against Actinobacillus pleuropneumoniae with two recombinant protein preparations. Vaccine 105:512-518.
43. Schryvers, A. B., and L. J. Morris. 1988. Identification and characterization of the human lactoferrin-binding protein from Neisseria meningitidis. Infect. Immun. 56:1144-1149.
44. Schryvers, A. B., and L. J. Morris. 1988. Identification and characterization of the transferrin receptor from Neisseria meningitidis. Mol. Microbiol. 2:281-288.
45. Seiler, A., R. Reinhardt, J. Sarkari, D. A. Caugant, and M. Achtman. 1996. Allelic polymorphism and site-specific recombination in the opc locus of Neisseria meningitidis. Mol. Microbiol. 19:841-856.
46. Sierra, G. V., H. C. Campa, N. M, Varcacel, I. L. Garcia, P. L. Izquierdo, P. F. Sotolongo, G. V. Casanueva, C. O. Rico, C. R. Rodriguez, and M. H. Terry. 1991. Vaccine against group B Neisseria meningitidis: protection trial and mass vaccination results in Cuba. NIPH Ann. 14:195-207.
47. Stevenson, P., P. Williams, and E. Griffiths. 1992. Common antigenic domains in transferrin-binding protein 2 of Neisseria meningitidis, Neisseria gonorrhoea, and Haemophilus influenzae type b. Infect. Immun. 60:2391-2396.
48. Stojiljkovic, I., V. Hwa, L. Desaint-Martin, P. Ogaora, X. Nassif, F. Heffron, and M. So. 1995. The Neisseria meningitidis haemoglobin receptor: its role in iron utilization and virulence. Mol. Microbiol. 15:531-541.
49. Stojilkovic, I., L. Jason, V. Hwa, S. Anic, and M. So. 1996. HmbR outer membrane receptors of pathogenic Neisseria spp.: iron-regulated, hemoglobin-binding proteins with a high level of primary-structure conservation. J. Bacteriol. 178:4670-4678.
50. Towbin, H., T. Staehelin, and J. Gordon. 1979. Electrophoresis transfer of protein from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA 76:4350-4354.
51. Vonder Haar, R. H., M. Legrain, and E. Jacobs. 1994. Characterization of a highly structured domain in Tbp2 from Neisseria meningitidis involved in binding to human transferrin. J. Bacteriol. 176:6207-6213.
52. Wang, J. F., D. A. Caugant, G. Morelli, B. Koumare, and M. Achtman. 1993. Antigenic and epidemiologic properties of the ET-37 complex of Neisseria meningitidis. J. Infect. Dis. 167:1320-1329.
53. Wyle, F. A., M. S. Arteinstein, B. L. Brandt, E. C. Tramont, D. L. Kasper, P. L. Altieri, S. L. Berman, and J. P. Lowenthal. 1972. Immunologic response of man to group B meningococcal polysaccharide vaccines. J. Infect. Dis. 126:514-522.
54. Zollinger, W., J. Boslego, E. Moran, J. Garcia, S. Ruiz, B. Brandt, W. Hankins, J. Mays, and J. Gilly. 1991. Meningococcal serogroup B vaccine: protection trial and follow up studies in Chile. NIPH Ann. 14:211-213.
55. Zollinger, W. D., R. E. Mandrell, J. M. Griffiss, P. Altiere, and S. Berman. 1979. Complex of meningococcal group B polysaccharide and type 2 outer membrane protein immunogenic in man. J. Clin. Invest. 63:836-848.